Demonstration of opsonic activity and in vivo protection against group B streptococci type III by Streptococcus pneumoniae type 14 antisera
- PMID: 29937
- PMCID: PMC2185002
- DOI: 10.1084/jem.148.3.776
Demonstration of opsonic activity and in vivo protection against group B streptococci type III by Streptococcus pneumoniae type 14 antisera
Abstract
The present studies demonstrate that antisera directed against Streptococcus pneumoniae type 14 is opsonic for group B streptococci type III in a neutrophile-mediated bactericidal assay. Specificity was demonstrated by the observations that group B streptococci type III and S. pneumoniae type 14 adsorbed the opsonic activity of anti-S. pneumoniae type 14 antisera. Group B streptococci strain 090R (devoid of type antigens) and S. pneumoniae type 3, did not remove the opsonic activity of anti-S. pneumoniae type 14 serum. In vivo studies using a suckling rat model of neonatal group B streptococcal type III sepsis demonstrated that antisera directed against S. pneumoniae type 14 was highly protective.
Similar articles
-
Immunoprecipitation and opsonic cross-reaction between type-14 pneumococcus and group-B streptococcus type III.Lancet. 1979 Jan;1(8107):75-7. doi: 10.1016/s0140-6736(79)90064-3. Lancet. 1979. PMID: 84130
-
Immunodeterminant specificity of human immunity to type III group B streptococcus.J Exp Med. 1979 Feb 1;149(2):327-39. doi: 10.1084/jem.149.2.327. J Exp Med. 1979. PMID: 84042 Free PMC article.
-
Type III group B streptococcal strain differences in susceptibility to opsonization with human serum.Pediatr Res. 1981 Dec;15(12):1525-9. doi: 10.1203/00006450-198112000-00015. Pediatr Res. 1981. PMID: 7033908
-
Immunoglobulin therapy of neonatal group B streptococcal infections: an overview.Pediatr Infect Dis J. 1988 May;7(5 Suppl):S13-6. Pediatr Infect Dis J. 1988. PMID: 3041355 Review.
-
C-reactive protein reactivity with complement and effects on phagocytosis.Ann N Y Acad Sci. 1982;389:251-62. doi: 10.1111/j.1749-6632.1982.tb22141.x. Ann N Y Acad Sci. 1982. PMID: 7046579 Review.
Cited by
-
Antibody to group B Streptococcus type III in human sera measured by a mouse protection test.Infect Immun. 1981 Apr;32(1):56-61. doi: 10.1128/iai.32.1.56-61.1981. Infect Immun. 1981. PMID: 7216494 Free PMC article.
-
Functional characteristics of a modified immunoglobulin preparation for intravenous administration: summary of studies of opsonic and protective activity against group B streptococci.J Clin Immunol. 1982 Apr;2(2 Suppl):31S-35S. doi: 10.1007/BF00918364. J Clin Immunol. 1982. PMID: 7045156
-
Experimental vaginal colonization and mother-infant transmission of group B streptococci in rats.Infect Immun. 1979 Nov;26(2):599-603. doi: 10.1128/iai.26.2.599-603.1979. Infect Immun. 1979. PMID: 397931 Free PMC article.
-
Quantitation of in vitro opsonic activity of human antibody induced by a vaccine consisting of the type III-specific polysaccharide of group B streptococcus.Infect Immun. 1983 Mar;39(3):1155-60. doi: 10.1128/iai.39.3.1155-1160.1983. Infect Immun. 1983. PMID: 6341229 Free PMC article.
-
The mode of action of antibody in neutrophil bactericidal activity against highly pathogenic group-B streptococci.Med Microbiol Immunol. 1984;173(2):65-74. doi: 10.1007/BF02124820. Med Microbiol Immunol. 1984. PMID: 6387419